Show Notes
"COPD is evolving. But we can manage it better and we should manage it better."
Guest Editors Peter M.A. Calverley and James P. Allinson join Dorina Esendagli (Monograph Editorial Board member) to discuss their issue of the Monograph: COPD in the 21st Century. COPD is widely acknowledged as a leading cause of death and, in this podcast, Peter and James suggest that incidence and mortality may actually increase further, as understanding and diagnosis improve. They also look to the future, highlighting ways in which care can be enhanced through greater personalisation and removal of stigma.
More from ERS Publications Podcasts
"We [should] not only focus on one treatment option but we should discuss how we can combine different options; this has to be studied in more detail"
As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Christina Thornton and associate editor Marcus Mall about their Back to Basics review article on bridging the airway microbiome and targeted therapy in bronchiectasis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.00239-2026).
As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Marlies van Dijk (University of Groningen, Groningen, The Netherlands) about her multicentre randomised crossover trial of fentanyl and morphine for persistent dyspnoea in COPD, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01431-2025).
As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marlies Wijsenbeek about data from the whole follow-up period of the FIBRONEER-ILD trial of nerandomilast in progressive pulmonary fibrosis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01272-2025).
"Making ultrasound as widespread and as used as the stethoscope... that's the big challenge going forwards"